Search results for "Schizophrenia spectrum"

showing 10 items of 16 documents

Association of parental communication deviance with offspring's psychiatric and thought disorders. A systematic review and meta-analysis.

2013

AbstractElevated number of parental Communication Deviance (CD) has been connected with psychiatric and thought disorders in their offspring. However, no earlier systematic efforts have been made to review this issue. The aim of this study was to survey the existing literature systematically and perform a meta-analysis of this association. A literature search for published and unpublished observational studies on the association of parental Communication Deviance with psychopathology in the offspring was conducted. Multiple electronic databases were searched (from 1960 to 2012) and the reference lists of the resulting publications were scanned. The findings were pooled using random effect m…

050103 clinical psychologymedicine.medical_specialtyOffspring05 social sciences030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineCommunication devianceMeta-analysisSystemic modelCommunication DisordersmedicineSchizophreniaHumans0501 psychology and cognitive sciencesObservational studyGene-Environment InteractionParent-Child RelationsPsychiatryAssociation (psychology)PsychologyPsychopathologySchizophrenia spectrumEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Cognitive and emotional empathy in patients with schizophrenia spectrum disorders: A replication and extension study.

2019

Impairments of social cognition are defined as core features in the pathology of schizophrenia. In a study by Lehmann and colleagues (2014), patients with schizophrenia have been shown to demonstrate a diminished capacity to understand others' emotions (i.e. cognitive empathy), but a preserved ability to share or feel the emotional states of others (i.e. emotional empathy). Here, we report on an independent replication study investigating cognitive and emotional empathy in 35 patients with schizophrenia spectrum disorders and a matched control group, which 1) confirms that patients demonstrate preserved emotional empathy in self-report and behavioural measurements, and 2) reveals associatio…

AdultMaleAnhedoniaEmotional empathymedia_common.quotation_subjectEmotionsEmpathy03 medical and health sciences0302 clinical medicineCognitionSocial cognitionmedicineHumansIn patientBiological Psychiatrymedia_commonAnhedoniaCognitionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomEmpathyPsychology030217 neurology & neurosurgeryClinical psychologySchizophrenia spectrumPsychiatry research
researchProduct

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

2012

AbstractBackgroundTo analyse insight of illness during the course of inpatient treatment, and to identify influencing factors and predictors of insight.MethodsInsight into illness was examined in 399 patients using the item G12 of the Positive and Negative Syndrome Scale (“lack of insight and judgement”). Ratings of the PANSS, HAMD, UKU, GAF, SOFAS, SWN-K and Kemp's compliance scale were performed and examined regarding their potential association with insight. The item G12 was kept as an ordinal variable to compare insight between subgroups of patients.ResultsAlmost 70% of patients had deficits in their insight into illness at admission. A significant improvement of impairments of insight …

AdultMaleOrdinal datamedicine.medical_specialtyMedizin03 medical and health sciences0302 clinical medicineTreatment targetsPredictive Value of TestsHamdmedicineHumansPsychiatryPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleAwarenessmedicine.disease030227 psychiatryPsychiatry and Mental healthInsight into illnessSchizophreniaAcute DiseaseSchizophreniaFemaleSchizophrenic PsychologyPsychology030217 neurology & neurosurgeryClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

Cerebellar parcellation in schizophrenia and bipolar disorder

2019

International audience; Objective: The cerebellum is involved in cognitive processing and emotion control. Cerebellar alterations could explain symptoms of schizophrenia spectrum disorder (SZ) and bipolar disorder (BD). In addition, literature suggests that lithium might influence cerebellar anatomy. Our aim was to study cerebellar anatomy in SZ and BD, and investigate the effect of lithium.Methods: Participants from 7 centers worldwide underwent a 3T MRI. We included 182 patients with SZ, 144 patients with BD, and 322 controls. We automatically segmented the cerebellum using the CERES pipeline. All outputs were visually inspected.Results: Patients with SZ showed a smaller global cerebellar…

AdultMalePathologymedicine.medical_specialtyCerebellumBipolar DisordercerebellumLithium (medication)[INFO.INFO-IM] Computer Science [cs]/Medical ImagingCerebellar Gray MatterCerebellar CortexYoung Adult03 medical and health sciences0302 clinical medicineAntimanic Agents[INFO.INFO-IM]Computer Science [cs]/Medical ImagingHumansMedicineBipolar disorderbusiness.industrysegmentationCognitionMiddle Agedmedicine.diseaseMagnetic Resonance Imaging030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structurenervous systemMulticenter studylithiumSchizophreniaparcellationLithium CompoundsSchizophreniaFemalebusiness030217 neurology & neurosurgerymedicine.drugSchizophrenia spectrumActa Psychiatrica Scandinavica
researchProduct

Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remissio…

2019

Despite being recommended for use in clinical trials, the consensus remission criteria were found to leave patients with persisting symptoms, relevant areas of functional impairment and a decreased sense of wellbeing. Therefore, to evaluate the appropriateness of the schizophrenia consensus criteria, a definition of remission based on the Clinical Global Impression Scale (CGI) was developed and remitter subgroups were compared.239 patients with a schizophrenia spectrum disorder were evaluated regarding their remission status after inpatient treatment. Remission in schizophrenia was defined according to the symptom-severity component of the consensus criteria by Andreasen et al. and a CGI ba…

AdultMalePediatricsmedicine.medical_specialtyConsensusMedizinConsensus criteriaSeverity of Illness IndexAsymptomaticYoung Adult03 medical and health sciences0302 clinical medicineRemission criteriaOutcome Assessment Health Caremental disordersmedicineHumansBiological PsychiatryDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryRemission InductionMiddle Agedmedicine.disease030227 psychiatry3. Good healthClinical trialPsychiatry and Mental healthSchizophreniaSchizophreniaClinical Global ImpressionFemalemedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesSchizophrenia spectrum
researchProduct

Response trajectories in "real-world" naturalistically treated schizophrenia patients.

2011

Abstract Background To date, research has identified distinct antipsychotic response trajectories yet focussing on data from randomized-controlled trials (RCTs). Therefore, the heterogeneity of response in “real-world” schizophrenia patients is still unknown. Methods Antipsychotic response was evaluated in 399 patients suffering from a schizophrenia spectrum disorder within a naturalistic multicenter study of the Competence Network on Schizophrenia using latent class regression. Baseline and illness-related variables were compared between the different trajectory classes as well as currently proposed outcome definitions (early improvement, response, remission) using univariate tests. In ord…

AdultMaleTime Factorsmedicine.medical_treatmentMedizin03 medical and health sciencesYoung Adult0302 clinical medicinemedicineHumansYoung adultAntipsychoticBiological PsychiatryRetrospective StudiesPsychiatric Status Rating ScalesUnivariateRetrospective cohort studyRegression analysisMiddle AgedResponse to treatment030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersHospitalizationPsychiatry and Mental healthTreatment OutcomeMulticenter studySchizophreniaRegression AnalysisFemaleSchizophrenic PsychologyPsychology030217 neurology & neurosurgeryClinical psychologySchizophrenia spectrumAntipsychotic AgentsFollow-Up StudiesSchizophrenia research
researchProduct

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder – When, Who, and How?

2017

Abstract The aim of this study was to evaluate antidepressant add-on treatment within the acute treatment of schizophrenia spectrum disorder patients. Antidepressant add-on was evaluated in 365 patients within a naturalistic multicenter study. Patients with/without antidepressant add-on were compared regarding clinical and treatment-related variables, response and remission, and remission of depressive and negative symptoms. The efficacy of antidepressant add-on treatment was furthermore analyzed applying marginal structure models. Twenty-three percent of the patients received antidepressant add-on for a mean duration of 50.28 (33.42) days. Patients with the diagnosis of a schizoaffective d…

AdultMalemedicine.medical_specialtyAdolescentMedizinSchizoaffective disorderDrug synergismYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansPharmacology (medical)Young adultPsychiatryDepressive symptomsAgedDepressionDrug SynergismGeneral MedicineMiddle Agedmedicine.diseaseAntidepressive Agents3. Good health030227 psychiatryClinical trialPsychiatry and Mental healthTreatment OutcomeMulticenter studySchizophreniaAntidepressantFemalePsychology030217 neurology & neurosurgeryAntipsychotic AgentsSchizophrenia spectrumPharmacopsychiatry
researchProduct

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

2014

AbstractBackground:Aim was to examine depressive symptoms in acutely ill schizophrenia patients on a single symptom basis and to evaluate their relationship with positive, negative and general psychopathological symptoms.Methods:Two hundred and seventy-eight patients suffering from a schizophrenia spectrum disorder were analysed within a naturalistic study by the German Research Network on Schizophrenia. Using the Calgary Depression Scale for Schizophrenia (CDSS) depressive symptoms were examined and the Positive and Negative Syndrome Scale (PANSS) was applied to assess positive, negative and general symptoms. Correlation and factor analyses were calculated to detect the underlying structur…

AdultMalemedicine.medical_specialtyDepression scaleMedizinSeverity of Illness Index03 medical and health sciences0302 clinical medicineGermanyPrevalencemedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive symptomsPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleDepressionGeneral symptomsMiddle Agedmedicine.disease030227 psychiatry3. Good healthHospitalizationAffectPsychiatry and Mental healthResearch DesignSchizophreniaAcute DiseaseGuiltSchizophreniaFemaleSchizophrenic PsychologyFactor Analysis StatisticalPsychologyPsychopathologyClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

Patterns of evidence integration in schizophrenia and delusion.

2011

Previous studies documented a bias against disconfirmatory evidence (BADE) in patients affected by schizophrenia spectrum disorders, with some discrepant findings on its relationship with delusions. In order to further investigate the patterns of evidence integration in schizophrenia and delusion, we recruited 40 deluded and non-deluded patients with schizophrenia and 40 healthy control subjects. Participants were administered the BADE test, which consisted of 30 delusion-neutral scenarios, each one progressively described by three subsequent disambiguating statements and providing four types of interpretation to rate for plausibility; at every additional evidence presentation, participants…

AdultMalemedicine.medical_specialtyHealthy subjectsMiddle AgedNeuropsychological Testsmedicine.diseaseCognitive biasDelusionsPsychiatry and Mental healthJudgmentDelusionSchizophreniaHealthy controlmedicineHumansIn patientFemaleSchizophrenic Psychologymedicine.symptomPsychologyPsychiatryBiological PsychiatryProblem SolvingSchizophrenia spectrumPsychiatry research
researchProduct

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders : Valid predictors of symptomatic response and remiss…

2010

To examine quality of life and subjective well-being as predictors of symptomatic treatment outcome.Biweekly PANSS ratings were performed in 285 inpatients with schizophrenia spectrum disorders within a multicenter trial by the German Research Network on Schizophrenia. Quality of life and subjective well-being were assessed using the Medical Outcomes Study-Short Form 36-Item Health Survey (SF-36), the Subjective Well-being Under Neuroleptic Treatment Scale (SWN-K) and the Adjective Mood Scale (AMS). Response was defined as an initial 20% PANSS total score reduction and remission according to the consensus criteria. Correlation analysis, logistic regression and CART-analysis were performed.I…

AdultMalemedicine.medical_specialtyMedizinLogistic regressionMood scale03 medical and health sciencesYoung Adult0302 clinical medicineQuality of lifeMulticenter trialInternal medicinemedicineHumansSubjective well-beingBiological PsychiatryPsychiatric Status Rating ScalesMiddle Agedmedicine.diseasePrognosisAntidepressive Agents3. Good health030227 psychiatryHospitalizationPsychiatry and Mental healthTranquilizing AgentsPsychotic DisordersSchizophreniaCorrelation analysisQuality of LifeSchizophreniaDrug Therapy CombinationFemaleSchizophrenic PsychologyPsychology030217 neurology & neurosurgerySchizophrenia spectrumClinical psychologyAntipsychotic Agents
researchProduct